Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | PTPRC | P08575 | 2/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSS | P25774 | 1/20 | 0.40 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.40 |
| ▸ | TDP2 | O95551 | 1/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30322608 | 0.86 | PDK2 (0.56) | PDK2KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL11990868 | 0.86 | PDK2 (0.56) | PDK2KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL19955995 | 0.86 | PDK2 (0.49) | PDK2KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL19886858 | 0.83 | PDK2 (0.53) | PDK2KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL32682807 | 0.80 | PDK2 (0.49) | PDK2KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL29419598 | 0.80 | PDK2 (0.49) | PDK2KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL5344736 | 0.80 | PDK2 (0.49) | PDK2KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL17701457 | 0.80 | KMT2A (0.39) | PDK2KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL21104282 | 0.80 | PDK2 (0.39) | PDK2KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL27954463 | 0.79 | KMT2A (0.55) | PDK2KMT2ACYP1A2CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306613-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE | Samsung Display Co., Ltd. (KR) | 2024-01-17 | — | — | EP | disclosed |
| US-20190185457-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2019-06-20 | — | — | US | disclosed |
| US-20160329509-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2016-11-10 | — | — | US | disclosed |
| US-20160329509-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2016-11-10 | — | — | US | disclosed |
| US-9478758-B1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-10-25 | — | — | US | disclosed |
| US-9478758-B1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190185457-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | CRY1, NAP1L1, CYP1A1 | PDK2 2435/4885KMT2A 769/4885CYP1A2 35/4885 |
| US-20160329509-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SOD1, SLC25A21, SLC25A11 | PDK2 1107/4885KMT2A 3230/4885CYP1A2 1310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.